天美传媒

M. Dolores Cimini is a New York State licensed psychologist who has provided leadership for comprehensive efforts in research-to-practice translation at the University at Albany since 1992 with over $9 million in support from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Education, U.S. Department of Justice, and New York State Office of Addiction Services and Supports. The screening and brief intervention program developed by Dr. Cimini, the STEPS Comprehensive Alcohol Screening and Brief Intervention Program, has earned 13 national awards for best practices and innovation in behavioral health care. 

Cimini is the director of the Middle Earth Peer Assistance Program at UAlbany, an agency recognized as a model/exemplary program in alcohol and other drug prevention by both the U.S. Department of Education and the Center for Substance Abuse Prevention, U.S. Department of Health and Human Services. She has published two books and numerous professional articles in both national and international refereed journals in the alcohol and substance use field and has earned two awards for excellence from the White House for her contributions to STEM mentoring. Cimini is a member of the Commission on Accreditation of the American Psychological Association and was the Past Chair of the APA Board for the Advancement of Psychology in the Public Interest, where she has had leadership for reviewing and disseminating APA鈥檚 practice standards focused on serving diverse and underrepresented groups and the addressing of issues related to psychology and social justice.

Jason McLellan specializes in understanding the structure and function of viral proteins, including those of coronaviruses. His research focuses on applying structural information to the rational design of vaccines and other therapies for viruses, including SARS-CoV-2, the novel coronavirus that causes COVID-19. McLellan and his team collaborated with researchers at the National Institute of Allergy and Infectious Diseases鈥� Vaccine Research Center to design a stabilized version of the SARS-CoV-2 spike protein, which forms the basis of several leading COVID-19 vaccine candidates, including those by Moderna, Novavax, Johnson & Johnson and Pfizer/BioNTech.

Dr. McLellan earned a BS in chemistry with an emphasis in biochemistry from Wayne State University in Detroit, Michigan. Afterward, he obtained his PhD from the Johns Hopkins University School of Medicine in Baltimore, Maryland in the laboratory of Dr. Daniel Leahy. He then carried out postdoctoral research at the National Institutes of Health's Vaccine Research Center in the laboratory of Dr. Peter Kwong and in collaboration with Dr. Barney Graham. In the Fall of 2013, he joined the faculty at the Geisel School of Medicine at Dartmouth in the Department of Biochemistry, and in January 2018 he moved his laboratory to the University of Texas at Austin and became a member of the Department of Molecular Biosciences.

Awards: 
2020 William Prusoff Memorial Award (International Society for Antiviral Research)

2019 Viruses Young Investigator in Virology Prize

2018 American Crystallographic Association Etter Early Career Award

2015 Charles H. Hood Foundation Child Health Research Award

2012 Norman P. Salzman Memorial Award in Virology